Pulmonary embolism and Lymphocyte count decreased

Summary:

Lymphocyte count decreased is found among people with Pulmonary embolism, especially for people who are male, 60+ old.

The study analyzes which people have Lymphocyte count decreased with Pulmonary embolism. It is created by eHealthMe based on reports of 19 people who have Pulmonary embolism from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,334 drugs and 2,958 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

What is Lymphocyte count decreased?

Lymphocyte count decreased is found to be associated with 1,209 drugs and 1,335 conditions by eHealthMe. Check the latest studies of Lymphocyte count decreased.



On Jul, 26, 2026

19 people who have Pulmonary Embolism and Lymphocyte Count Decreased are studied.

Would you have Lymphocyte count decreased when you have Pulmonary embolism?

Gender of people who have Pulmonary Embolism and experienced Lymphocyte Count Decreased *:

  • female: 38.89 %
  • male: 61.11 %

Age of people who have Pulmonary Embolism and experienced Lymphocyte Count Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 5.5600000000000005 %
  • 50-59: 27.78 %
  • 60+: 66.67 %

Common co-existing conditions for these people *:

  1. Breast Cancer: 3 people, 15.79%
  2. Breast Cancer Metastatic: 3 people, 15.79%
  3. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 3 people, 15.79%
  4. Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 10.53%
  5. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 10.53%
  6. Dehydration (dryness resulting from the removal of water): 2 people, 10.53%
  7. Muscle Spasms (muscle contraction): 2 people, 10.53%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.53%
  9. Metastases To Bone (cancer spreads to bone): 2 people, 10.53%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.26%

Common drugs taken by these people *:

  1. Innohep: 3 people, 15.79%
  2. Heparin: 3 people, 15.79%
  3. Kisqali: 3 people, 15.79%
  4. Clexane: 3 people, 15.79%
  5. Gilenya: 2 people, 10.53%
  6. Zestoretic: 2 people, 10.53%
  7. Lovenox: 2 people, 10.53%
  8. Dilaudid: 2 people, 10.53%
  9. Depo-Testosterone: 2 people, 10.53%
  10. Compazine: 2 people, 10.53%

Common symptoms for these people *:

  1. Thrombocytopenia (decrease of platelets in blood): 8 people, 42.11%
  2. Haematocrit Decreased: 7 people, 36.84%
  3. Fatigue (feeling of tiredness): 6 people, 31.58%
  4. Weakness: 6 people, 31.58%
  5. Diarrhea: 6 people, 31.58%
  6. Haemoglobin Decreased: 6 people, 31.58%
  7. Red Blood Cell Count Decreased: 5 people, 26.32%
  8. White Blood Cell Count Decreased: 5 people, 26.32%
  9. General Physical Health Deterioration (weak health status): 5 people, 26.32%
  10. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 26.32%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lymphocyte count decreased?

- Check whether Lymphocyte count decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Lymphocyte count decreased:

All the conditions that are associated with Lymphocyte count decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Lymphocyte count decreased and Pulmonary embolism, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: